1. Home
  2. FNWB vs IBIO Comparison

FNWB vs IBIO Comparison

Compare FNWB & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$10.05

Market Cap

86.7M

Sector

Finance

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.87

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
IBIO
Founded
1923
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.7M
72.2M
IPO Year
2012
2009

Fundamental Metrics

Financial Performance
Metric
FNWB
IBIO
Price
$10.05
$1.87
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$13.50
$4.75
AVG Volume (30 Days)
25.4K
726.0K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
0.70%
N/A
EPS Growth
36.00
73.08
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$0.56
52 Week High
$10.98
$3.82

Technical Indicators

Market Signals
Indicator
FNWB
IBIO
Relative Strength Index (RSI) 59.24 54.38
Support Level $9.18 $1.70
Resistance Level $10.34 $2.00
Average True Range (ATR) 0.29 0.13
MACD 0.04 0.05
Stochastic Oscillator 82.57 78.23

Price Performance

Historical Comparison
FNWB
IBIO

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: